Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Tyrosine Kinase Inhibitors
>>
Phase 4
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
21
42
63
84
105
126
147
168
189
210
imatinib
/ Generic mfg.
sunitinib
/ Generic mfg.
Votrient
(pazopanib) / Novartis, BeiGene
Focus V
(anlotinib) / Advenchen, Sino Biopharm
AiTan
(rivoceranib) / HLB Bio Group
Stivarga
(regorafenib) / Bayer
everolimus
/ Generic mfg.
Tasigna
(nilotinib) / Novartis, Inhibikase
Ayvakit
(avapritinib) / Blueprint Medicines